Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 2/20 | 0.39 |
| ▸ | SCN4A | P35499 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | LTA4H | P09960 | 1/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.36 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.36 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.36 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.34 |
| ▸ | DPP4 | P27487 | 2/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7564026 | 0.85 | SLC6A4 (0.44) | SLC6A4SCN4ATSHRLTA4HADRA2A | |
| SCHEMBL2031146 | 0.81 | SLC6A4 (0.41) | SLC6A4SCN4ATSHRLTA4HADRA2A | |
| SCHEMBL10942730 | 0.77 | SLC6A4 (0.39) | SLC6A4SCN4ATSHRLTA4HADRA2A | |
| SCHEMBL8518703 | 0.77 | SLC6A4 (0.39) | SLC6A4SCN4ATSHRLTA4HADRA2A | |
| SCHEMBL2035765 | 0.77 | CA4 (0.44) | SLC6A4SCN4ATSHRLTA4HADRA2A | |
| SCHEMBL18297941 | 0.74 | THRB (0.41) | TSHRDPP4F2CA4 | |
| SCHEMBL16382776 | 0.74 | NPSR1 (0.47) | SLC6A4TSHR | |
| SCHEMBL11666723 | 0.72 | SLC6A4 (0.36) | SLC6A4SCN4ATSHRLTA4HADRA2A | |
| SCHEMBL7644220 | 0.72 | SLC6A4 (0.36) | SLC6A4SCN4ATSHRLTA4HADRA2A | |
| SCHEMBL8717190 | 0.71 | LMNA (0.42) | SLC6A4TSHRCA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3103805-B1 | SILANOL COMPOUND, COMPOSITION, AND METHOD FOR PRODUCING SILANOL COMPOUND | AIST (JP) | 2020-11-18 | — | — | EP | disclosed |
| US-10308670-B2 | Silanol compound, composition, and method for producing silanol compound | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2019-06-04 | — | — | US | disclosed |
| US-20170183363-A1 | Silanol Compound, Composition, and Method for Producing Silanol Compound | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2017-06-29 | — | — | US | disclosed |
| EP-3103805-A1 | SILANOL COMPOUND, COMPOSITION, AND METHOD FOR PRODUCING SILANOL COMPOUND | National Institute of Advanced Industrial Science and Technology (JP) | 2016-12-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170183363-A1 | Silanol Compound, Composition, and Method for Producing Silanol Compound | LSS, MSMO1, ALG3 | SLC6A4 4216/4885SCN4A 2186/4885TSHR 4865/4885 |
| US-10308670-B2 | Silanol compound, composition, and method for producing silanol compound | LSS, MSMO1, ALG3 | SLC6A4 4216/4885SCN4A 2186/4885TSHR 4865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.